Macrophage glutathione content and glutathione peroxidase activity are inversely related to cell-mediated oxidation of LDL: In vitro and in vivo studies

Free Radical Biology and Medicine

Volumn 24, Issue 2, 1998, Pages 305-317

  Rosenblat, Mira ^a   Aviram, Michael ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Glutathione; Glutathione peroxidase; LDL; Lipid peroxidation; Macrophages; Selenium

Indexed keywords

2 OXO 4 THIAZOLIDINECARBOXYLIC ACID; APOLIPOPROTEIN E; BUTHIONINE SULFOXIMINE; CYSTEINE; GLUTATHIONE; GLUTATHIONE SYNTHASE; GLUTATHIONE SYNTHASE INHIBITOR; LOW DENSITY LIPOPROTEIN; OXYGENASE; SELENIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; MACROPHAGE MIGRATION INHIBITION; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN METABOLISM;

ANIMALS; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BUTHIONINE SULFOXIMINE; CELL LINE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIPOPROTEINS, LDL; MACROPHAGES; MACROPHAGES, PERITONEAL; MICE; MICE, TRANSGENIC; OXIDATION-REDUCTION; PEROXIDES; PYRROLIDONECARBOXYLIC ACID; SELENIUM; SUPEROXIDES; THIAZOLES; THIAZOLIDINES;

ANIMALIA;

EID: 0031975264     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(97)00231-1     Document Type: Article

References (66)

1. Yla-Herttuala S., Palinski W., Rosenfeld M. E., Parthasarathy S., Carew T. E., Butler S., Witztum J. L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1989;1086-1095.
2. Aviram M., Maor I., Keidar S., Hayek T., Oiknine J., Bar-El Y., Adler Z., Kertzman V., Milo S. Lesioned low density lipoprotein in atherosclerotic apolipoprotein E-deficient transgenic mice and in humans is oxidized and aggregated. Biochem. Biophys. Res. Commun. 216:1995;501-513.
3. Lavy A., Brook G. J., Dankner G., Ben Amotz A., Aviram M. Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism. 40:1991;794-799.
4. Keidar S., Kaplan M., Shapira C., Brook J. G., Aviram M. Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: A possible role for angiotensin II. Atherosclerosis. 107:1994;71-84.
5. Beaudeux J. L., Guillausseau P. J., Peynet J., Flourie F., Assayag M., Tielmans D., Warnet A., Rousselet F. Enhanced susceptibility of low-density lipoprotein to in vitro oxidation in type 1 and type 2 diabetic patients. Clin. Chim. Acta. 239:1995;131-141.
6. Sutherland W. H., Walker R. J., Ball M. J., Stapley S. A., Robertson M. C. Oxidation of low density lipoproteins from patients with renal failure or renal transplants. Kidney Int. 48:1995;227-236.
7. Hoffman R., Brook J. G., Aviram M. Hypolipidemic therapy reduce lipoprotein susceptibility to undergo lipid peroxidation: In vitro and ex vivo studies. Atherosclerosis. 93:1992;105-113.
8. Carew T. E., Schwenke D. C., Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. USA. 84:1987;7725-7729.
9. Bjorkhem I., Henriksson-Freyschuss A., Breuer O., Diczfalusy U., Berglund L., Henriksson P. The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler. Thromb. 11:1991;15-22.
10. Williams R. J., Motteram J. M., Sharp C. H., Gallagher P. J. Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Artherosclerosis. 94:1992;153-159.
11. Gerrity R. G. The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Pathol. 103:1981;181-190.
12. Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
13. Mitchinson M. J., Hothersall D. C., Brooks P. N., De Burbure C. Y. The distribution of ceroid in human atherosclerosis. J. Pathol. 145:1985;177-183.
14. Parthasarathy S., Printz D. J., Boyd D., Joy L., Steinberg D. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis. 6:1996;505-510.
15. Leake D. S., Rankin S. M. The oxidative modification of low-density lipoproteins by macrophages. Biochem. J. 270:1990;741-748.
16. Parthasarathy S., Steinberg D. Cell-induced oxidation of LDL. Curr. Opin. Lipidol. 3:1992;313-317.
17. Aviram M., Rosenblat M. Macrophage-mediated oxidation of extracellular low density lipoprotein requires an initial binding of the lipoprotein to its receptor. J. Lipid Res. 35:1994;385-398.
18. Rankin S. M., Parthasarathy S., Steinberg D. Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. J. Lipid. Res. 32:1991;449-456.
19. Aviram M., Rosenblat M., Etzioni A., Levy R. Activation of NADPH oxidase is required for macrophage-mediated oxidation of low-density lipoprotein. Metabolism. 45:1996;1069-1079.
20. Aviram M., Rosenblat M. Phospholipase A2 and phospholipase D are involved in macrophage NADPH oxidase-mediated oxidation of low-density lipoprotein. Isr. J. Med. Sci. 32:1996;749-756.
21. Sparrow C. P., Olszewski J. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. J. Lipid. Res. 34:1993;1219-1228.
22. Graham A., Wood J. L., O'Leary V. J., Stone D. Human (THP-1) macrophages oxidize LDL by thiol-dependent mechanism. Free. Radic. Res. 21:1994;295-308.
23. Santanam N., Parthasarathy S. Cellular cysteine generation does not contribute to the initiation of LDL oxidation. J. Lipid. Res. 36:1995;2203-2211.
24. Heinecke J. W., Rosen H., Suzuki L. A., Chait A. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J. Biol. Chem. 262:1987;10098-10103.
25. Heinecke J. W., Kawamura M., Suzuki L., Chait A. Oxidation of low density lipoprotein by thiols: Superoxide-dependent and- independent mechanisms. J. Lipid Res. 34:1993;2051-2061.
26. Meister A., Anderson M. E. Glutathione. Annu. Rev. Biochem. 52:1983;711-760.
27. Pichoner H., Metodiewa D., Winterbourn C. C. Generation of superoxide and tyrosine peroxide as a result of tyrosyl radical scavenging by glutathione. Arch. Biochem. Biophys. 323:1995;429-437.
28. Flohe L., Gunzler W. A., Coschen G. The glutathione peroxidase reaction: A key to understand the selenium requirement of mammals. Kharasch N. Trace metals in health and disease. 1979;263-286 Raven Press, New York.
29. Schuckelt R., Brigelius-Flohe R., Maiorino M., Roveri A., Reumkens J., Strassburger W., Ursini F., Wolf B., Flohe L. Phospholipid hydroperoxide glutathione peroxidase is a selenoenzyme distinct from the classical glutathione peroxidase as evident from cDNA and amino acid sequencing. Free Radic. Res. Commun. 14:1991;343-361.
30. Brigelius-Flohe R., Aumann K. D., Blocker H., Gross G., Kiess M., Kloppel K. D., Maiorino M., Roveri A., Schuckelt R., Usani F., et al. Phospholipid-hydroxide glutathione peroxidase. Genomic DNA, cDNA, and deduced amino acid sequence. J. Biol. Chem. 269:1994;7342-7348.
31. Sandstrom B. E., Carlsson J., Marklund S. L. Variations among cultured cells in glutathione peroxidase activity in reponse to selenite supplementation. Biochim. Biophys. Acta. 929:1987;148-153.
32. Baker R. D., Baker S. S., LaRosa K., Whitney C., Newburger P. E. Selenium regulation of glutathione peroxidase in human hepatoma cell line Hep 3B. Arch. Biochem. Biophys. 304:1993;53-57.
33. Liu J. Z., Zhang B. Z., Milner J. A. Dietary selenite modifies glutathione metabolism and 7, 12-dimethyl benz (a) anthracene conjugation in rats. J. Nutr. 124:1994;172-180.
34. Girelli D., Olivieri O., Stanzial A. M., Azzini M., Lupo A., Bernich P., Menini C., Gammaro L., Corrocher R. Low platelet glutathione peroxidase activity and serum selenium concentration in patients with chronic renal failure: relations to dialysis treatments, diet and cardiovascular complications. Clin. Sci. 84:1993;611-617.
35. Kuzuya M., Naito M., Funaki C., Hayashi T., Asai K., Kuzuya F. Protective role of intracellular glutathione against oxidized low density lipoprotein in cultured endothelial cells. Biochem. Biophys. Res. Commun. 163:1989;1466-1472.
36. Thomas J. P., Geriger P. G., Girotti A. W. Lethal damage to endothelial cells by oxidized low density lipoprotein: Role of selenoperoxidases in cytoprotection against lipid hydroperoxide and iron-mediated reactions. J. Lipid. Res. 34:1993;479-490.
37. Gotoh N., Graham A., Nikl E., Darley-Usmar V. M. Inhibition of glutathione synthesis increases the toxicity of oxidized low-density lipoproteins to human monocytes and macrophages. Biochem. J. 296:1994;151-154.
38. Griffith O. W., Meister A. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J. Biol. Chem. 254:1979;7558-7560.
39. Williamson J. M., Meister A. Stimulation of hepatic glutathione formation by administration of L-2-oxothiazolidine-4-carboxylate, a 5-oxo-L prolinase substrate. Proc. Natl. Acad. Sci. USA. 78:1981;936-939.
40. Plump A. S., Smith J. D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J. G., Rubin E. M., Breslow J. L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:1992;343-353.
41. Aviram M. Low density lipoprotein modification by cholesterol oxidase induces enhanced uptake and cholesterol accumulation in cells. J. Biol. Chem. 267:1992;218-225.
42. Aviram M., Williams K. J., McIntosh R. A., Carpentier Y. A., Tall A. R., Deckelbaum R. J. Intralipid infusion abolishes ability of human serum to cholesterol-load cultured macrophages. Arteriosclerosis. 9:1989;67-75.
43. Aviram M. Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. Biochem. Med. 30:1983;111-118.
44. Buege J. A., Aust S. D. Microsomal lipid peroxidation. Methods Enzymol. 52:1978;302-310.
45. El-Saadani M., Esterbauer H., El-Sayed M., Goher M., Nassar A. Y., Jurgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid. Res. 30:1989;627-630.
46. Lowry O. H., Rosebrough N. J., Farr L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
47. Griffith O. W., Meister A. Excretion of cysteine and gamma-glutamyl cysteine moieties in human and experimental animal with gamma glutamyl transpepitase deficiency. Proc. Natl. Acad. Sci. USA. 77:1980;3384-3387.
48. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Application to mammalian blood and other tissues. Anal. Biochem. 27:1969;502-522.
49. Thomas J. P., Maiorino M., Ursini F., Girotti A. W. Protective action of phospholipid hydroperoxide glutathione peroxidase against membrane-damaging lipid peroxidation. In situ reduction of phospholipid and cholesterol hydroperoxides. J. Biol. Chem. 265:1990;454-461.
50. Johnston R. B., Keele B. B. Jr., Misra H. P., Lehmeyer J. E., Webb L. S., Baehner R. L., RaJagopalan K. V. The role of superoxide anion generation in phagocytic bactericidal activity. J. Clin. Invest. 55:1975;1357.
51. Blois M. S. Antioxidant determination by the use of a stable free radical. Nature. 181:1958;1199-1200.
52. Fuhrman B., Oiknine J., Aviram M. Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties. Atherosclerosis. 111:1994;65-78.
53. Fuhrman B., Oiknine J., Keidar S., Ben-Yaish L., Kaplan M., Aviram M. Increased uptake of low density lipoprotein (LDL) by oxidized macrophages is the result of an initial enhanced LDL receptor activity and of a further progressive oxidation of LDL. Free Radic. Biol. Med. 23:1997;34-46.
54. Keidar S., Kaplan M., Hoffman A., Aviram M. Angiotensin II stimulates macrophage-mediated oxidation of low density lipoprotein. Atherosclerosis. 115:1995;201-215.
55. Tsan M.F., Phillips P. G. L-2-Oxothiazolidine-4-carboxylate protects cultured endothelial cells against hyperoxia-induced injury. Inflammation. 12:1988;113-121.
56. Hayek T., Oiknine J., Brook J. G., Aviram M. Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice. Biochem. Biophys. Res. Commun. 201:1994;1567-1574.
57. Hayek T., Rosenblat M., Aviram M. Increased platelet activation in the atherosclerotic, apolipoprotein E-deficient transgenic mice; Role of plasma lipoproteins and platelet composition. Eur. J. Lab. Med. 4:1996;147-153.
58. Smith C., Mitchinson M. J., Aruoma O. I., Halliwell B. Stimulation of lipid peroxidation and hydroxy-radical generation by the contents of human atherosclerotic lesions. Biochem. J. 286:1992;901-905.
59. Jornot L., Junod A. F. Variable glutathione levels and expression of antioxidant enzymes in human endothelial cells. Am. J. Physiol. 264:1993;L482-L489.
60. Ochi T. Inhibition of the activity of glutathione peroxidase by tertiary-butylhydroperoxide in cultured Chinese hamster cells and the role of cellular glutathione in the recovery of the activity. Toxicology. 71:1992;119-127.
61. Vessey D. A., Lee K. H. Inactivation of enzymes of the glutathione antioxidants system by treatment of cultured human keratinocytes with peroxides. J. Invest. Dermatol. 100:1993;829-833.
62. Ljubuncic P., Fuhrman B., Oiknine J., Aviram M., Bomzon A. The effect of decoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages. Gut. 39:1996;475-478.
63. Bedwell S., Dean R. T., Jessup W. The action of defined oxygen-centred free radicals on human low-density lipoprotein. Biochem. J. 262:1989;707-712.
64. Schoneich C., Asmus K. D., Dillinger U., von Bruchhausen F. Thiyl radical attack on polyunsaturated fatty acids; A possible route to lipid peroxidation. Biochem. Biophys. Res. Commun. 161:1989;113-120.
65. Hussein O., Rosenblat M., Rafael G., Aviram M. Dietary selenium increases cellular glutathione peroxidase activity and reduces the enhanced susceptibility to lipid peroxidation of plasma and low density lipoprotein in kidney transplanted patients. Transplantation. 63:1996;679-685.
66. Salonen J. T. The role of lipid peroxidation, antioxidants and pro-oxidants in atherosclerosis. Acta. Cardiol. 48:1993;457-459.